Earnings Call Summary | MEDICINE MAN TECHNOLOGIES INC(SHWZ.US) Q4 2023 Earnings Conference
Earnings Call Summary | MEDICINE MAN TECHNOLOGIES INC(SHWZ.US) Q4 2023 Earnings Conference
The following is a summary of the Medicine Man Technologies, Inc. (SHWZ) Q4 2023 Earnings Call Transcript:
以下是 Medicine Man Technologies, Inc. (SHWZ) 2023年第四季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
Medicine Man Technologies (Schwazze) reported Q4 revenue of $43.3 million, up by 8%.
The company had a significant gross profit of $7 million (16% of total revenue) with an adjusted gross profit of 47% of the total revenue.
Operating expenses decreased compared to the previous year, accounting for 54% of the revenues.
The company reported an operating loss of $16.2 million.
Schwazze ended the year with a cash position of approximately $19 million and generated $12 million from its operations.
Medicine Man Technologies（Schwazze）公佈的第四季度收入爲4,330萬美元，增長了8％。
該公司的可觀毛利潤爲700萬美元（佔總收入的16％），調整後的毛利爲總收入的47％。
與上年相比，運營費用有所下降，佔收入的54％。
該公司報告的營業虧損爲1,620萬美元。
Schwazze年底的現金狀況約爲1900萬美元，其運營收入爲1200萬美元。
Business Progress:
業務進展：
Schwazze reported a high single-digit sales growth and expanded its store footprint by more than 50% in competitive markets.
There is expected store closure in New Mexico due to regulatory efforts, and this is expected to continue through 2024.
Wholesale penetration improved three times in 2023, exceeding 27% in Colorado and New Mexico.
The company plans to launch Lowell Farms in New Mexico and Everyday Weed in Colorado in Q2 2024.
Expectations of regulatory changes could have a significant impact on cash flow generation and the overall perspective of the cannabis industry.
The company aims to continue its retail development in New Mexico and Colorado and is exploring new brand development.
Schwazze報告了較高的個位數銷售增長，並在競爭激烈的市場中將其門店足跡擴大了50％以上。
由於監管措施，預計新墨西哥州的門店將關閉，這種情況預計將持續到2024年。
2023 年，批發滲透率提高了三倍，科羅拉多州和新墨西哥州的批發滲透率超過 27%。
該公司計劃於2024年第二季度在新墨西哥州推出洛厄爾農場，在科羅拉多州推出Everyday Weed。
對監管變化的預期可能會對現金流的產生和大麻行業的整體前景產生重大影響。
該公司的目標是繼續在新墨西哥州和科羅拉多州的零售發展，並正在探索新的品牌發展。
More details: MEDICINE MAN TECHNOLOGIES INC IR
更多詳情： 藥人科技公司 IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。